Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.

The global Immunoglobulin G Antibody Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Immunoglobulin G Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulin G Antibody Therapeutics.

Report Scope

The Immunoglobulin G Antibody Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunoglobulin G Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunoglobulin G Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immunoglobulin G Antibody Therapeutics Market Report

Report Metric	Details
Report Name	Immunoglobulin G Antibody Therapeutics Market
CAGR	5%
Segment by Type	IgG1 IgG4 Others
Segment by Application	Autoimmune Tumor Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbvie, J & J, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, UCB, Eli Lilly and Company, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunoglobulin G Antibody Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immunoglobulin G Antibody Therapeutics Market report?

Ans: The main players in the Immunoglobulin G Antibody Therapeutics Market are Roche, Abbvie, J & J, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, UCB, Eli Lilly and Company, AstraZeneca

What are the Application segmentation covered in the Immunoglobulin G Antibody Therapeutics Market report?

Ans: The Applications covered in the Immunoglobulin G Antibody Therapeutics Market report are Autoimmune, Tumor, Others

What are the Type segmentation covered in the Immunoglobulin G Antibody Therapeutics Market report?

Ans: The Types covered in the Immunoglobulin G Antibody Therapeutics Market report are IgG1, IgG4, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 IgG1

1.2.3 IgG4

1.2.4 Others

1.3 Market by Application

1.3.1 Global Immunoglobulin G Antibody Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Autoimmune

1.3.3 Tumor

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunoglobulin G Antibody Therapeutics Market Perspective (2019-2030)

2.2 Immunoglobulin G Antibody Therapeutics Growth Trends by Region

2.2.1 Global Immunoglobulin G Antibody Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immunoglobulin G Antibody Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Immunoglobulin G Antibody Therapeutics Market Dynamics

2.3.1 Immunoglobulin G Antibody Therapeutics Industry Trends

2.3.2 Immunoglobulin G Antibody Therapeutics Market Drivers

2.3.3 Immunoglobulin G Antibody Therapeutics Market Challenges

2.3.4 Immunoglobulin G Antibody Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunoglobulin G Antibody Therapeutics Players by Revenue

3.1.1 Global Top Immunoglobulin G Antibody Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Immunoglobulin G Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immunoglobulin G Antibody Therapeutics Revenue

3.4 Global Immunoglobulin G Antibody Therapeutics Market Concentration Ratio

3.4.1 Global Immunoglobulin G Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunoglobulin G Antibody Therapeutics Revenue in 2023

3.5 Immunoglobulin G Antibody Therapeutics Key Players Head office and Area Served

3.6 Key Players Immunoglobulin G Antibody Therapeutics Product Solution and Service

3.7 Date of Enter into Immunoglobulin G Antibody Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunoglobulin G Antibody Therapeutics Breakdown Data by Type

4.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2025-2030)

5 Immunoglobulin G Antibody Therapeutics Breakdown Data by Application

5.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immunoglobulin G Antibody Therapeutics Market Size (2019-2030)

6.2 North America Immunoglobulin G Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024)

6.4 North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunoglobulin G Antibody Therapeutics Market Size (2019-2030)

7.2 Europe Immunoglobulin G Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024)

7.4 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size (2019-2030)

9.2 Latin America Immunoglobulin G Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Immunoglobulin G Antibody Therapeutics Introduction

11.1.4 Roche Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Abbvie

11.2.1 Abbvie Company Detail

11.2.2 Abbvie Business Overview

11.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Introduction

11.2.4 Abbvie Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.2.5 Abbvie Recent Development

11.3 J & J

11.3.1 J & J Company Detail

11.3.2 J & J Business Overview

11.3.3 J & J Immunoglobulin G Antibody Therapeutics Introduction

11.3.4 J & J Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.3.5 J & J Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Detail

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Introduction

11.4.4 Bristol-Myers Squibb Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Immunoglobulin G Antibody Therapeutics Introduction

11.5.4 Novartis Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.5.5 Novartis Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Immunoglobulin G Antibody Therapeutics Introduction

11.6.4 Merck Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.6.5 Merck Recent Development

11.7 Alexion Pharmaceuticals

11.7.1 Alexion Pharmaceuticals Company Detail

11.7.2 Alexion Pharmaceuticals Business Overview

11.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Introduction

11.7.4 Alexion Pharmaceuticals Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.7.5 Alexion Pharmaceuticals Recent Development

11.8 Takeda

11.8.1 Takeda Company Detail

11.8.2 Takeda Business Overview

11.8.3 Takeda Immunoglobulin G Antibody Therapeutics Introduction

11.8.4 Takeda Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.8.5 Takeda Recent Development

11.9 Amgen

11.9.1 Amgen Company Detail

11.9.2 Amgen Business Overview

11.9.3 Amgen Immunoglobulin G Antibody Therapeutics Introduction

11.9.4 Amgen Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.9.5 Amgen Recent Development

11.10 Biogen

11.10.1 Biogen Company Detail

11.10.2 Biogen Business Overview

11.10.3 Biogen Immunoglobulin G Antibody Therapeutics Introduction

11.10.4 Biogen Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.10.5 Biogen Recent Development

11.11 UCB

11.11.1 UCB Company Detail

11.11.2 UCB Business Overview

11.11.3 UCB Immunoglobulin G Antibody Therapeutics Introduction

11.11.4 UCB Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.11.5 UCB Recent Development

11.12 Eli Lilly and Company

11.12.1 Eli Lilly and Company Company Detail

11.12.2 Eli Lilly and Company Business Overview

11.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Introduction

11.12.4 Eli Lilly and Company Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.12.5 Eli Lilly and Company Recent Development

11.13 AstraZeneca

11.13.1 AstraZeneca Company Detail

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Introduction

11.13.4 AstraZeneca Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

11.13.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alexion Pharmaceuticals

Eli Lilly and Company

Astrazeneca plc

List of Tables

Table 1. Global Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of IgG1

Table 3. Key Players of IgG4

Table 4. Key Players of Others

Table 5. Global Immunoglobulin G Antibody Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Immunoglobulin G Antibody Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Immunoglobulin G Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Immunoglobulin G Antibody Therapeutics Market Share by Region (2019-2024)

Table 9. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Immunoglobulin G Antibody Therapeutics Market Share by Region (2025-2030)

Table 11. Immunoglobulin G Antibody Therapeutics Market Trends

Table 12. Immunoglobulin G Antibody Therapeutics Market Drivers

Table 13. Immunoglobulin G Antibody Therapeutics Market Challenges

Table 14. Immunoglobulin G Antibody Therapeutics Market Restraints

Table 15. Global Immunoglobulin G Antibody Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Immunoglobulin G Antibody Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Immunoglobulin G Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2023)

Table 18. Ranking of Global Top Immunoglobulin G Antibody Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Immunoglobulin G Antibody Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Immunoglobulin G Antibody Therapeutics Product Solution and Service

Table 22. Date of Enter into Immunoglobulin G Antibody Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Immunoglobulin G Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Immunoglobulin G Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Roche Company Detail

Table 48. Roche Business Overview

Table 49. Roche Immunoglobulin G Antibody Therapeutics Product

Table 50. Roche Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 51. Roche Recent Development

Table 52. Abbvie Company Detail

Table 53. Abbvie Business Overview

Table 54. Abbvie Immunoglobulin G Antibody Therapeutics Product

Table 55. Abbvie Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Abbvie Recent Development

Table 57. J & J Company Detail

Table 58. J & J Business Overview

Table 59. J & J Immunoglobulin G Antibody Therapeutics Product

Table 60. J & J Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 61. J & J Recent Development

Table 62. Bristol-Myers Squibb Company Detail

Table 63. Bristol-Myers Squibb Business Overview

Table 64. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Product

Table 65. Bristol-Myers Squibb Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Bristol-Myers Squibb Recent Development

Table 67. Novartis Company Detail

Table 68. Novartis Business Overview

Table 69. Novartis Immunoglobulin G Antibody Therapeutics Product

Table 70. Novartis Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Novartis Recent Development

Table 72. Merck Company Detail

Table 73. Merck Business Overview

Table 74. Merck Immunoglobulin G Antibody Therapeutics Product

Table 75. Merck Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Merck Recent Development

Table 77. Alexion Pharmaceuticals Company Detail

Table 78. Alexion Pharmaceuticals Business Overview

Table 79. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Product

Table 80. Alexion Pharmaceuticals Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Alexion Pharmaceuticals Recent Development

Table 82. Takeda Company Detail

Table 83. Takeda Business Overview

Table 84. Takeda Immunoglobulin G Antibody Therapeutics Product

Table 85. Takeda Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Takeda Recent Development

Table 87. Amgen Company Detail

Table 88. Amgen Business Overview

Table 89. Amgen Immunoglobulin G Antibody Therapeutics Product

Table 90. Amgen Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 91. Amgen Recent Development

Table 92. Biogen Company Detail

Table 93. Biogen Business Overview

Table 94. Biogen Immunoglobulin G Antibody Therapeutics Product

Table 95. Biogen Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 96. Biogen Recent Development

Table 97. UCB Company Detail

Table 98. UCB Business Overview

Table 99. UCB Immunoglobulin G Antibody Therapeutics Product

Table 100. UCB Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 101. UCB Recent Development

Table 102. Eli Lilly and Company Company Detail

Table 103. Eli Lilly and Company Business Overview

Table 104. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Product

Table 105. Eli Lilly and Company Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 106. Eli Lilly and Company Recent Development

Table 107. AstraZeneca Company Detail

Table 108. AstraZeneca Business Overview

Table 109. AstraZeneca Immunoglobulin G Antibody Therapeutics Product

Table 110. AstraZeneca Revenue in Immunoglobulin G Antibody Therapeutics Business (2019-2024) & (US$ Million)

Table 111. AstraZeneca Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immunoglobulin G Antibody Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Immunoglobulin G Antibody Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. IgG1 Features

Figure 4. IgG4 Features

Figure 5. Others Features

Figure 6. Global Immunoglobulin G Antibody Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Immunoglobulin G Antibody Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Autoimmune Case Studies

Figure 9. Tumor Case Studies

Figure 10. Others Case Studies

Figure 11. Immunoglobulin G Antibody Therapeutics Report Years Considered

Figure 12. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Immunoglobulin G Antibody Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Immunoglobulin G Antibody Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Immunoglobulin G Antibody Therapeutics Market Share by Players in 2023

Figure 16. Global Top Immunoglobulin G Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Immunoglobulin G Antibody Therapeutics Revenue in 2023

Figure 18. North America Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Immunoglobulin G Antibody Therapeutics Market Share by Country (2019-2030)

Figure 20. United States Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Immunoglobulin G Antibody Therapeutics Market Share by Country (2019-2030)

Figure 24. Germany Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Region (2019-2030)

Figure 32. China Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Immunoglobulin G Antibody Therapeutics Market Share by Country (2019-2030)

Figure 40. Mexico Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Share by Country (2019-2030)

Figure 44. Turkey Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Roche Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 47. Abbvie Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 48. J & J Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 51. Merck Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 52. Alexion Pharmaceuticals Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 53. Takeda Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 54. Amgen Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 55. Biogen Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 56. UCB Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 57. Eli Lilly and Company Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 58. AstraZeneca Revenue Growth Rate in Immunoglobulin G Antibody Therapeutics Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions